Literature DB >> 17925571

Radiation-induced prevention of erlotinib-induced skin rash is transient: a new aspect toward the understanding of epidermal growth factor receptor inhibitor associated cutaneous adverse effects.

Peter Arne Gerber, Elaine Enderlein, Bernhard Homey, Anja Muller, Edwin Boelke, Wilfried Budach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17925571     DOI： 10.1200/JCO.2007.12.8330

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

Review 1.  [Therapy with epidermal growth factor receptor inhibitors. Clinical spectrum of cutaneous adverse effects].

Authors:  P A Gerber; B A Buhren; S Kürle; B Homey
Journal:  Hautarzt       Date:  2010-08       Impact factor: 0.751

2.  Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients.

Authors:  Peter Arne Gerber; Stephan Meller; Tatiana Eames; Bettina Alexandra Buhren; Holger Schrumpf; Sonja Hetzer; Laura Maximiliane Ehmann; Wilfried Budach; Edwin Bölke; Christiane Matuschek; Andreas Wollenberg; Bernhard Homey
Journal:  Eur J Med Res       Date:  2012-02-23       Impact factor: 2.175

Review 3.  [Cutaneous side effects of targeted cancer drugs].

Authors:  J Below; B Homey; P A Gerber
Journal:  Hautarzt       Date:  2017-01       Impact factor: 0.751

4.  Erlotinib-induced rash spares previously irradiated skin.

Authors:  Irene M Lips; Mariska E Y Koster; Ronald H Houwing; Ernest J A Vonk
Journal:  Strahlenther Onkol       Date:  2011-07-25       Impact factor: 3.621

5.  Lack of Cetuximab induced skin toxicity in a previously irradiated field: case report and review of the literature.

Authors:  Madhava R Kanakamedala; Satyaseelan Packianathan; Srinivasan Vijayakumar
Journal:  Radiat Oncol       Date:  2010-05-17       Impact factor: 3.481

Review 6.  Skin toxicities associated with epidermal growth factor receptor inhibitors.

Authors:  Tianhong Li; Roman Perez-Soler
Journal:  Target Oncol       Date:  2009-05-19       Impact factor: 4.493

7.  Radiotherapy and erlotinib combined: review of the preclinical and clinical evidence.

Authors:  Vivek K Mehta
Journal:  Front Oncol       Date:  2012-04-10       Impact factor: 6.244

Review 8.  Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors.

Authors:  L Peuvrel; C Bachmeyer; Z Reguiai; J B Bachet; T André; R J Bensadoun; O Bouché; M Ychou; B Dréno
Journal:  Support Care Cancer       Date:  2012-02-24       Impact factor: 3.359

Review 9.  Mechanisms underlying skin disorders induced by EGFR inhibitors.

Authors:  Martin Holcmann; Maria Sibilia
Journal:  Mol Cell Oncol       Date:  2015-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.